KROS EPS Estimates
Keros Therapeutics, Inc.
$11.95
+$0.31(+2.66%)
56
Overall
80
Value
45
Tech
44
Quality
Market Cap
$230.79M
Volume
194.16K
52W Range
$9.69 - $22.55
Target Price
$18.86
KROS EPS estimates: the consensus estimate for Keros Therapeutics, Inc.'s current fiscal year is -$5.27 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
KROS EPS Estimates
- EPS estimate, current quarter
- $-0.96
- EPS estimate, next quarter
- $-1.72
- EPS estimate, current year
- $-5.27
- EPS estimate, next year
- $-6.39
- EPS growth, 3-year
- +36.87%
| Fiscal year | EPS |
|---|---|
| 2025 | $2.34 |
| 2024 | $-5.00 |
| 2023 | $-5.20 |
| 2022 | $-4.15 |
| 2021 | $-2.52 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $11.95 | +2.7% | 194.16K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Keros Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW